PROTHENA CORPORATION PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.1 USD | -6.90% |
|
-14.07% | -44.69% |
| May. 09 | RBC Cuts Price Target on Prothena to $28 From $35, Keeps Sector Perform, Speculative Risk | MT |
| May. 08 | Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000 | MT |
Chart calendar Prothena Corporation plc
9ca3ec7107744db7f5ba4eb8aa9df.PEiG8Zqm6uhjAAA0qa6NRFyLSuHR5B52G8FhgA_me8Y.azrWqfOTiaBXeG19xMnmaR7Te5Ogjyw6NokvuVatAat-JL6D69bSrDRhMA~7697342fde9c18fbe667393e6fbc7e17
Upcoming events on Prothena Corporation plc
Past events on Prothena Corporation plc
| 2024-05-14 11:00 am | Annual General Meeting |
| 2024-05-08 04:05 pm | Q1 2024 Earnings Release |
| 2024-03-12 | Jefferies Biotech on the Bay Summit |
| 2024-03-12 10:00 am | Leerink Partners Global Biopharma Conference - Fireside Chat |
| 2024-02-15 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-15 04:05 pm | Q4 2023 Earnings Release |
| 2023-11-02 04:05 pm | Q3 2023 Earnings Release |
| 2023-09-11 02:15 pm | Morgan Stanley Global Healthcare Conference |
| 2023-09-06 | Citi BioPharma Conference |
| 2023-08-03 04:05 pm | Q2 2023 Earnings Release |
| 2023-07-15 | Alzheimer Association International Conference - Poster No #74811 |
| 2023-07-15 | Alzheimer Association International Conference - Poster No #82687 |
| 2023-07-15 | Alzheimer Association International Conference - Poster No #74181 |
| 2023-06-08 01:00 pm | Jefferies Global Healthcare Conference |
| 2023-05-16 11:00 am | Annual General Meeting |
| 2023-05-09 12:20 pm | Bank of America Healthcare Conference |
| 2023-05-04 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-31 12:20 pm | Alzheimer & Parkinson Disease International Conference - Panel |
| 2023-03-31 09:20 am | Alzheimer & Parkinson Disease International Conference - Abstract number: 2480 |
| 2023-03-30 03:40 am | Alzheimer & Parkinson Disease International Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,81 0,72 12.94% | 0,85 0,64 32.86% | 201 205 -2.39% | 53,9 43,0 25.33% | 91,4 89,4 2.17% | 15,1 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -111 -116 3.94% | 73,1 75,2 -2.82% | 0,00 -146 - | -190 -274 30.63% | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -85,7 -86,0 0.38% | -113 -115 1.57% | 72,0 79,5 -9.44% | -132 -146 10.06% | -191 -194 1.41% | -289 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -77,3 -78,4 1.4% | -111 -111 -0.62% | 71,9 87,8 -18.12% | -126 -140 10.51% | -160 -168 4.73% | -262 |
|
Net income Million USD | Released Forecast Spread | -77,7 -78,8 1.45% | -111 -111 0.3% | 67,0 68,4 -2.03% | -117 -140 16.5% | -147 -153 4.15% | -251 |
|
EPS USD | Released Forecast Spread | -1,95 -1,98 1.39% | -2,78 -2,79 0.26% | 1,38 1,44 -3.88% | -2,47 -2,93 15.67% | -2,76 -2,87 3.99% | -4,70 |
| Announcement Date | 12/02/20 | 11/02/21 | 17/02/22 | 23/02/23 | 15/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,15 10,1 -88.53% | 1,31 17,2 -92.36% | 1,52 25,2 -93.98% | 49,9 29,1 71.33% | 2,17 7,53 -71.18% | 4,02 4,52 -11.13% | 84,9 41,7 103.56% | 0,32 2,72 -88.39% | 0,05 2,17 -97.69% | 1,84 | 1,84 | 11,4 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -37,9 -29,8 -27.31% | -43,2 -23,7 -82.66% | -50,3 -23,4 -114.78% | -0,07 -27,3 99.74% | -56,3 -40,5 -38.94% | -66,5 -52,9 -25.67% | 10,3 -27,3 137.69% | -78,5 -76,8 -2.19% | -81,5 -73,2 -11.34% | -74,1 | -73,7 | -60,2 | -80,7 | -82,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -38,0 -25,5 -48.78% | -42,6 -31,4 -35.52% | -48,4 -39,7 -21.9% | 3,35 -22,6 114.8% | -49,8 -46,3 -7.62% | -58,9 -60,0 1.84% | 18,8 -35,6 152.87% | -70,6 -74,6 5.3% | -74,4 -69,4 -7.22% | -68,6 | -68,8 | -51,6 | -70,2 | -72,2 |
|
Net income Million USD | Released Forecast Spread | -36,3 -29,7 -21.98% | -41,2 -23,6 -74.59% | -45,8 -23,3 -96.18% | 6,35 -26,4 124.05% | -46,9 -40,0 -17.3% | -54,6 -50,0 -9.27% | 21,9 -18,6 217.64% | -67,5 -67,0 -0.65% | -72,2 -65,3 -10.65% | -65,7 | -65,9 | -51,7 | -75,6 | -77,6 |
|
EPS USD | Released Forecast Spread | -0,78 -0,66 -18.18% | -0,88 -0,57 -54% | -0,97 -0,56 -72.44% | 0,12 -0,49 124.71% | -0,89 -0,81 -10.46% | -1,03 -0,97 -5.7% | 0,38 -0,32 217.93% | -1,26 -1,23 -2.72% | -1,34 -1,22 -9.99% | -1,22 | -1,21 | -1,01 | -1,47 | -1,52 |
| Announcement Date | 05/05/22 | 08/08/22 | 03/11/22 | 23/02/23 | 04/05/23 | 03/08/23 | 02/11/23 | 15/02/24 | 08/05/24 | - | - | - | - | - |
More events
Past sector events for Prothena Corporation plc
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-15 04:01 pm | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PRTA Stock
- Calendar Prothena Corporation plc
